Contact us   |  

Transversal fields of action

Methodological approach of EuroBloodNet has been shaped in accordance with ongoing EU activities to contribute to innovative, efficient and sustainable health systems and facilitate access to better and safer healthcare for EU citizens. Our efforts to improve the delivery of cross-border care to RHD patients will be undertaken in accordance with the Directive on Cross-Border Healthcare (2011/24/EU).

Five Transversal Field of Actions (TFAs) were defined aligned with the objectives defined in order to implement target driven actions to ensure their achievement:

TFA 1 Cross border health

TFA on cross-border health aims to establish a referral system for patients and samples in order to ensure the same level of access to healthcare across Europe.

TFA 2 Best practices

TFA on best practices aims to compile, create, and assess their implementation, alongside disseminating guidelines in RHD

TFA 3 Continuing medical education

TFA on CME aims to spread cutting-edge knowledge and facilitate continuous medical education in the field of RHD.

TFA 4 Telemedicine

TFA on Tele-medicine aims to facilitate inter-professional consultation by sharing of expertise and safety exchange of clinical information.

TFA 5 Clinical trials and research.

TFA on Clinical Trials and Research aims to foster European cooperation for epidemiological surveillance, development of high specialized procedures for diagnosis, innovative treatments and research.

Transversal Fields of Action Coordinators

  Cross border health
Oncological Pierre Fenaux Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis
Non oncological Raffaella Colombatti Azienda Ospedaliera Università di Padova
ePAG Ananda Plate Myeloma Patients Europe
  Best practices
Oncological Luca Malcovati Fondazione IRCCS Policlinico San Matteo (Pavia)
Non oncological Paola Bianchi Foundation IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milan
ePAG Amanda Bok European Haemophilia Consortium (EHC)
  Continuing medical education
Oncological Dominique Bron Institut Jules Bordet
Non oncological Patricia Aguilar-Martinez Montpellier University Hospital (CHU de Montpellier)
ePAG Jan Geissler Leukemia Patient Advocates Foundation
  Tele-medicine
Oncological Adèle De Masson & Martine Bagot Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis
Non oncological Béatrice Gulbis CUB-Hôpital Erasme
ePAG Sophie Wintrich MDS UK Patient Support Group (and MDS Alliance)
  Clinical Trials and Research
Oncological

Clinical Trials: Pierre Fenaux

Research & Registries: Matteo Della Porta

Clinical Trials: Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis

Research & Registries: IRCCS Humanitas Research Hospital (Milan)

Non oncological

Clinical Trials: Andreas Glenthoj

Research & Registries: María del Mar Mañú Pereira

Clinical Trials: Copenhagen University Hospital - Rigshospitalet

Research & Registries: Hospital Universitari Vall d'Hebron

ePAG Angelo Loris Brunetta Thalassaemia International Federation - Associazione Ligure Thalassemici Onlus

Euro Blood Net